CTRI/2018/02/011893
Completed
Phase 2
A Clinical Study To evaluate the efficacy Of Ayurvedic formulations in the management of Sandhigata Vata w.s.r. Osteoarthritis.
Principal RGGPG Ayurvedic College and Hospital Paprola0 sites20 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- patients fulfilling the inclusion criteria and willing for trial
- Sponsor
- Principal RGGPG Ayurvedic College and Hospital Paprola
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patient willing to undergo trial and ready to give written consent.
- •2\.Patients presenting with classical features of sandhigata vata.
Exclusion Criteria
- •1\.Patients not willing for trial.
- •2\.Patients below the age of 30 yrs and above 70 years
- •3\.Diabetes mellitus with complications like neuropathy, arthropathy and nephropathy
- •4\. Known case of Malignancy, Psoriatic arthritis, Tuberculosis, Vata rakta, Phiranga, S.L.E.
- •5\.Patients showing any allergy to trial drug.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Ayurvedic treatment for diabetic macular edemaHealth Condition 1: H350- Background retinopathy and retinalvascular changesCTRI/2023/05/053154Banaras Hindu University
Completed
Phase 2
Management of avascular necrosis of femoral head in AyurvedaHealth Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissueCTRI/2021/03/031621All India Institute of Ayurveda15
Recruiting
Phase 4
A clinical study to assess the efficacy and safety of Ayurvedic treatment Kneesol oil to compare with Dr Ortho oil and Diclofenac gel in Rheumatoid arthritis patients.CTRI/2023/04/052114Madhusudan Healthcare
Not yet recruiting
Not Applicable
Role Of Ayurveda Treatment Protocol In Garbhasayagata Arbuda With Special Reference To Uterine FibroidCTRI/2024/06/069012ational Institute of AyurvedaJaipur Rajasthan
Not yet recruiting
Phase 2
Effect of the test product in reducing dark spotsCTRI/2024/03/064874Hindustan Unilever Limited